D. Scott Coward - Feb 19, 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ D. Scott Coward by Mark Busch, attorney-in- fact
Stock symbol
EXAS
Transactions as of
Feb 19, 2025
Transactions value $
-$33,103
Form type
4
Date filed
2/21/2025, 04:30 PM
Previous filing
Dec 20, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +2.25K +4.44% $0.00 52.8K Feb 19, 2025 Direct F1
transaction EXAS Common Stock Tax liability -$33.1K -667 -1.26% $49.63 52.2K Feb 19, 2025 Direct F2
holding EXAS Common Stock 4.69K Feb 19, 2025 by IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -2.25K -100% $0.00 0 Feb 19, 2025 Common Stock 2.25K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Represents a restricted stock unit award granted on February 19, 2021 that vests in four equal annual installments from the grant date.